Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

33.86
BATS BZX Real-Time Price
As of 2:32pm ET
 +0.12 / +0.36%
Today’s Change
29.83
Today|||52-Week Range
37.39
+4.25%
Year-to-Date
Akorn Is Highly Coveted, But Tea Leaves Don't Spell Bidding War
11:51am / TheStreet.com - Paid Partner Content
Is J&J's Pharma Sales Slowdown a Warning for Other Players?
Apr 19 / Zacks.com - Paid Partner Content
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
Apr 24 / Zacks.com - Paid Partner Content
Quotient Investors, LLC Buys ON Semiconductor, Willis Towers Watson PLC, Brookdale Se...
Apr 19 / GuruFocus News - Paid Partner Content
Trump Executive Order Could Revive Allergan-Pfizer Merger
Apr 21 / TheStreet.com - Paid Partner Content
Lackluster J&J Q1 Pushes Healthcare ETFs Down
Apr 19 / Zacks.com - Paid Partner Content
TherapeuticsMD Hormone Pill Faces Looming FDA Rejection and a Hostile Commercial Mark...
Apr 21 / TheStreet.com - Paid Partner Content
Why Is Pfizer (PFE) Up 8.7% Since the Last Earnings Report?
Apr 19 / Zacks.com - Paid Partner Content
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies
Apr 20 / Zacks.com - Paid Partner Content
Investors bet on Incyte drug success
Apr 19 / FT.com - Paid Partner Content

Today’s Trading

Previous close33.74
Today’s open33.82
Day’s range33.72 - 33.96
Volume850,660
Average volume (3 months)23,602,357
Market cap$200.9B
Dividend yield3.78%
Data as of 2:32pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.50%
Earnings growth (next 5 years)+5.40%
Revenue growth (last year)+8.13%
P/E ratio29.0
Price/Sales3.79
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+1.63+2.18%
MRKMerck+0.33+0.53%
SNYSanofi+0.43+0.94%
ABBVAbbVie+0.72+1.11%
Data as of 2:32pm ET, 04/25/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.67
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs